Effect of left ventricular function on long-term left ventricular pacing and sensing threshold

Journal of Interventional Cardiac Electrophysiology

Volumn 9, Issue 1, 2003, Pages 21-24

  Tse, Hung Fat ^a   Yu, Cannas ^a   Paul, Vince E ^b   Boriani, Giuseppe ^c   Schuchert, Andreas ^d   Del Ojo, Juan Leal ^e   Malinowski, Klaus ^g   Blanc, Jean Jacques ^f   Lau, Chu Pak ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HAREFIELD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f BREST UNIVERSITY HOSPITAL   (France)

^g NONE

Author keywords

Left ventricular function; Pacing; Threshold

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; CORRELATION ANALYSIS; DEVICE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; PARAMETER; PRIORITY JOURNAL; R WAVE; SENSING THRESHOLD; SICK SINUS SYNDROME; SYSTOLE; TREATMENT INDICATION;

AGED; CARDIAC PACING, ARTIFICIAL; ELECTRIC IMPEDANCE; HEART BLOCK; HEART FAILURE, CONGESTIVE; HUMANS; SENSORY THRESHOLDS; SICK SINUS SYNDROME; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0141427586     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025312319011     Document Type: Article

References (11)

1. Barold SS. What is cardiac resynchronization therapy? Am J Med 2001;111:224-232.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J, MIRACLE Study Group. Multicenter InSync randomized clinical evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
3. Alonso C, Leclercq C, d'Allonnes FR, Pavin D, Victor F, Mabo P, Daubert JC. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: Technical aspects. Heart 2001;86:405-410.
4. Hansky B, Vogt J, Gueldner H, Lamp B, Tenderich G, Krater L, Heintze J, Minami K, Horstkotte D, Koerfer R. Left heart pacing-experience with several types of coronary vein leads. J Interv Card Electrophysiol 2002;6:71-75.
5. Tse HF, Yu C, Lee KL, Yu CM, Tsang V, Leung SK, Lau CP. Initial clinical experience with a new self-retaining left ventricular lead for permanent left ventricular pacing. Pacing Clin Electrophysiol 2000;23:1738-1740.
6. Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O, Mugica J. Multisite pacing for end-stage heart failure: Early experience. PACE 1996;19:1748-1757.
7. Daubert JC, Ritter P, Le Breton H, Gras D, Leclercq C, Lazarus A, Mugica J, Mabo P, Cazeau S. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. PACE 1998;21:239-245.
8. Dohrmann ML, Goldschlager NF. Myocardial stimulation threshold in patients with cardiac pacemakers: Effect of physiologic variables, pharmacologic agents, and lead electrodes. Cardiol Clin 1985;3:527-537.
9. Marchlinski FE, Zado ES, Deely MP, Saligan J, Ashar M, Nayak H. Concomitant device and drug therapy: Current trends, potential benefits, and adverse interactions. Am J Cardiol 1999;84:69R-75R.
10. Purerfellner H, Nesser HJ, Winter S, Schwierz T, Hornell H, Maertens S. Transvenous left ventricular lead implantation with the EASYTRAK lead system: The European experience. Am J Cardiol 2000;86:K157-K164.
11. Schwaab B, Frohlig G, Berg M, Schwerdt H, Schieffer H. Five-year follow-up of a bipolar steroid-eluting ventricular pacing lead. Pacing Clin Electrophysiol 1999;22:1226-1228.